Clostridium difficile DNA (2 Challenges) EQA/PT Scheme

To assess the proficiency of laboratories in the molecular detection of Clostridium difficile.

Total Number of Challenges: 2
Number of Panel Members: 5
Distribution / Testing Period: Q2 & Q4
Sample NA Target Source Cultured and/or Clinical material
Matrix Panel Format Microbiological Medium and/or Synthetic Faecal Matrix
Panel Member Target Range Covering clinical range
Panel Member Sample Volume 1.0 ml
Panel Sample Pre-treatment Requirement Ready for analysis. Pre-treatment may be required for SFM. Follow test manufacturers IFU.
Panel Analysis Type Qualitative
Panel Testing Evaluated by various molecular methodologies
Storage / Shipment Conditions <-20°C / Frozen on Dry-ice
Accreditation / Regulatory Status Accredited to ISO 17043
SKU: QAB084125_2 Categories: , , Tags: ,

$1,228.58